AIM ImmunoTech holds 2025 annual meeting; all director nominees elected, say-on-pay advisory approved by votes cast

AIM ImmunoTech Inc.

All five director nominees elected with majority of votes cast; broker non-votes of 833,173 on each.
Ratification of BDO USA as auditor approved: 1,104,780 for, 29,754 against, 9,849 abstain.
Advisory say-on-pay approved by 193,668 for vs 115,337 against, but failed due to 833,173 broker non-votes.
Advisory vote on frequency selected 1 year (284,856 votes), consistent with board recommendation.
Quorum of 41.4% (1,144,383 shares) present; 2,764,188 shares outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.